Ding Qi-long

1.1k total citations
16 papers, 903 citations indexed

About

Ding Qi-long is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Ding Qi-long has authored 16 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Ding Qi-long's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Flavonoids in Medical Research (3 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Ding Qi-long is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Flavonoids in Medical Research (3 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Ding Qi-long collaborates with scholars based in China, United States and India. Ding Qi-long's co-authors include Khalil Ali Ahmad, Abdoh Taleb, Awais Ullah Ihsan, Hui Lei, Qineng Ping, Can Zhang, Huiping Zhou, Guowei Qu, Yao Zhong and Qinglong Guo and has published in prestigious journals such as Biomaterials, Free Radical Biology and Medicine and Polymer.

In The Last Decade

Ding Qi-long

16 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ding Qi-long China 14 312 175 122 92 91 16 903
Soon‐Sun Hong South Korea 20 414 1.3× 74 0.4× 108 0.9× 61 0.7× 60 0.7× 53 1.3k
Zarrin Banikazemi Iran 13 518 1.7× 83 0.5× 138 1.1× 57 0.6× 92 1.0× 19 1.3k
Mohammad Kashif Iqubal India 17 316 1.0× 125 0.7× 90 0.7× 74 0.8× 79 0.9× 44 1.2k
Mohammad Ahmed Khan India 20 473 1.5× 129 0.7× 98 0.8× 77 0.8× 160 1.8× 96 1.4k
Caroline Gaucher France 19 341 1.1× 199 1.1× 247 2.0× 62 0.7× 43 0.5× 45 1.2k
Martina Daga Italy 15 660 2.1× 112 0.6× 146 1.2× 103 1.1× 42 0.5× 24 1.5k
Rana Shafabakhsh Iran 21 783 2.5× 115 0.7× 122 1.0× 53 0.6× 76 0.8× 45 1.6k
Vikas Srivastava India 17 325 1.0× 110 0.6× 169 1.4× 29 0.3× 94 1.0× 46 1.2k
Jian Hou China 25 764 2.4× 151 0.9× 123 1.0× 84 0.9× 108 1.2× 92 1.7k
Haibo Cheng China 21 506 1.6× 107 0.6× 59 0.5× 134 1.5× 123 1.4× 79 1.1k

Countries citing papers authored by Ding Qi-long

Since Specialization
Citations

This map shows the geographic impact of Ding Qi-long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding Qi-long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding Qi-long more than expected).

Fields of papers citing papers by Ding Qi-long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ding Qi-long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding Qi-long. The network helps show where Ding Qi-long may publish in the future.

Co-authorship network of co-authors of Ding Qi-long

This figure shows the co-authorship network connecting the top 25 collaborators of Ding Qi-long. A scholar is included among the top collaborators of Ding Qi-long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ding Qi-long. Ding Qi-long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Taleb, Abdoh, Jifang Zhou, Jie Yang, et al.. (2019). Pharmacological strategies to lower crosstalk between nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and mitochondria. Biomedicine & Pharmacotherapy. 111. 1478–1498. 50 indexed citations
2.
Ahmad, Khalil Ali, et al.. (2019). Chitosan oligosaccharides prevent doxorubicin-induced oxidative stress and cardiac apoptosis through activating p38 and JNK MAPK mediated Nrf2/ARE pathway. Chemico-Biological Interactions. 305. 54–65. 64 indexed citations
4.
Taleb, Abdoh, Khalil Ali Ahmad, Awais Ullah Ihsan, et al.. (2018). Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases. Biomedicine & Pharmacotherapy. 102. 689–698. 166 indexed citations
5.
Chen, Jichao, Tianyu Wang, Ding Qi-long, et al.. (2017). Antioxidant Properties of Novel Dimers Derived from Natural β-Elemene through Inhibiting H2O2-Induced Apoptosis. ACS Medicinal Chemistry Letters. 8(4). 443–448. 24 indexed citations
6.
Ahmad, Khalil Ali, et al.. (2017). Antioxidant therapy for management of oxidative stress induced hypertension. Free Radical Research. 51(4). 428–438. 99 indexed citations
7.
Wang, Bing, et al.. (2016). Involvement of xanthine oxidase and paraoxonase 1 in the process of oxidative stress in nonalcoholic fatty liver disease. Molecular Medicine Reports. 15(1). 387–395. 26 indexed citations
8.
Li, Wenjun, Ding Qi-long, Youxiang Ding, et al.. (2016). Oroxylin A reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12/CXCR7 axis in bone marrow microenvironment. Molecular Carcinogenesis. 56(3). 863–876. 23 indexed citations
9.
Zhang, Xu, et al.. (2014). Clematichinenoside inhibits VCAM-1 and ICAM-1 expression in TNF-α-treated endothelial cells via NADPH oxidase-dependent IκB kinase/NF-κB pathway. Free Radical Biology and Medicine. 78. 190–201. 67 indexed citations
10.
Zhou, Yuxin, Na Lu, Haiwei Zhang, et al.. (2013). HQS-3, a newly synthesized flavonoid, possesses potent anti-tumor effect in vivo and in vitro. European Journal of Pharmaceutical Sciences. 49(4). 649–658. 8 indexed citations
11.
Jiang, Liying, Susu Tang, Xiaoyun Wang, et al.. (2012). PPARγ Agonist Pioglitazone Reverses Memory Impairment and Biochemical Changes in a Mouse Model of Type 2 Diabetes Mellitus. CNS Neuroscience & Therapeutics. 18(8). 659–666. 86 indexed citations
12.
Ding, Ya, Peng Zhang, Xiaoyan Tang, et al.. (2012). PEG prodrug of gambogic acid: Amino acid and dipeptide spacer effects. Polymer. 53(8). 1694–1702. 14 indexed citations
13.
Peng, Jun, et al.. (2011). Effects of Baicalein on Rat Myocardial Ischemia and Neonatal Cardiomyocyte Injury. Chinese Journal of Natural Medicines. 9(2). 132–140. 6 indexed citations
14.
Zhang, Can, Guowei Qu, Xiaoli Wu, et al.. (2008). Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials. 29(9). 1233–1241. 167 indexed citations
15.
Zhang, Can, Guowei Qu, Tao Yang, et al.. (2008). Biological evaluation of N-octyl-O-sulfate chitosan as a new nano-carrier of intravenous drugs. European Journal of Pharmaceutical Sciences. 33(4-5). 415–423. 45 indexed citations
16.
Qi-long, Ding, et al.. (2004). Effect of Baicalein on Experimental Prostatic Hyperplasia in Rats and Mice. Biological and Pharmaceutical Bulletin. 27(3). 333–337. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026